NXTC logo

NextCure, Inc. (NXTC)

Profile

Full Name

NextCure, Inc.

Ticker

NASDAQ: NXTC

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

May 9, 2019

Indexes

Not included

Website

https://www.nextcure.com

Employees

43

Key Details

Price

$5.67(+3.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$23.88(-961.33% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.67
    NXTC price is $5.67

    30-Day Relative Volume

    2.69
    NXTC 30-day relative volume is 2.69

    Price Performance

    Price Today change

    +3%
    NXTC price is up +3% today

    Price YTD change

    -38.77%
    NXTC price is down -38.77% since January 1st

    Price 1-year change

    -64.51%
    NXTC price is down -64.51% year-on-year

    Price 3-year change

    -87.8%
    NXTC price is down -87.8% over the past 3 years

    Price Range

    Price All-time high

    $1308.00
    NXTC price is currently -99.57% below its historical high of $1308.00

    Price 3-year low

    $2.69
    NXTC price is currently +110.75% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $15.16M
    NXTC market capitalization is $15.16 million

    Market cap 3-year change

    -85.88%
    NXTC market capitalization is down -85.88% over the past 3 years

    Market cap All-time high

    $2.10B
    NXTC market capitalization is currently -99.28% below its historical high of $2.10 billion

    Market cap sector rank

    19.88%
    NXTC market capitalization is higher than 19.88% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +14.79%
    NXTC shares outstanding is up +14.79% year-on-year

    Shares Outstanding 3-Year Change

    +15.73%
    NXTC shares outstanding is up +15.73% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.27
    NXTC beta is 0.27

    200-day SMA

    $7.17
    NXTC price is currently -21.02% below its 200-day simple moving average

    50-day SMA

    $5.14
    NXTC price is currently +10.20% above its 50-day simple moving average

    RSI

    61.03
    NXTC 14-day relative strength index is 61.03

    Volume

    2.69
    NXTC 30-day relative volume is 2.69

    ATR

    $0.32
    NXTC average true range is $0.32

    10-day Historical Volatility

    46.27%
    NXTC 10-day historical volatility is 46.27%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NXTC annual revenue is $0.00

    Revenue Analysts estimate

    -
    NXTC annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    NXTC annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.79%
    NXTC annual revenue is higher than 28.79% of companies in Healthcare sector

    EPS

    EPS

    -$23.88
    NXTC annual earnings per share is -$23.88

    EPS Analysts estimate

    -$15.59
    NXTC annual earnings per share is currently +53.21% higher than the consensus analysts' forecast

    EPS 1-year change

    -961.33%
    NXTC annual earnings per share is down -961.33% year-on-year

    EPS Sector rank

    6.88%
    NXTC annual earnings per share is higher than 6.88% of companies in Healthcare sector

    Profit

    Gross profit

    -$2.87M
    NXTC annual gross profit is -$2.87 million

    Gross margin

    -
    NXTC annual gross profit margin value is unknown

    Operating profit

    -$57.21M
    NXTC annual operating income is -$57.21 million

    Operating margin

    -
    NXTC annual operating profit margin value is unknown

    Net income

    -$55.65M
    NXTC annual net profit is -$55.65 million

    Net margin

    -
    NXTC annual net profit margin value is unknown

    Expenses

    Total expenses

    $57.21M
    NXTC annual total expenses is $57.21 million

    Operating expenses

    $57.21M
    NXTC annual total operating expenses is $57.21 million

    Cost of goods sold

    $2.87M
    NXTC annual cost of goods sold is $2.87 million

    Selling, general & administrative expenses

    $15.72M
    NXTC annual SGA is $15.72 million

    Depreciation and amortization

    $2.87M
    NXTC annual depreciation & amortization is $2.87 million

    Interest expense

    $0.00
    NXTC annual interest expense is $0.00

    Income tax

    $0.00
    NXTC annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$57.21M
    NXTC annual earnings before interest & taxes is -$57.21 million

    EBITDA

    -$54.34M
    NXTC annual EBITDA is -$54.34 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $81.92M
    NXTC annual total assets is $81.92 million

    Non current assets

    $9.05M
    NXTC annual long term assets is $9.05 million

    Current assets

    $71.81M
    NXTC annual total current assets is $71.81 million

    Cash and cash equivalents

    $27.73M
    NXTC annual cash & cash equivalents is $27.73 million

    Accounts receivable

    -
    NXTC annual accounts receivable value is unknown

    Inventory

    $0.00
    NXTC annual inventory is $0.00

    Liabilities

    Total liabilities

    $16.45M
    NXTC annual total liabilities is $16.45 million

    Long term liabilities

    $5.81M
    NXTC annual total long term liabilities is $5.81 million

    Current liabilities

    $9.57M
    NXTC annual total current liabilities is $9.57 million

    Accounts payable

    $5.35M
    NXTC annual accounts payable is $5.35 million

    Debt

    Total debt

    $5.95M
    NXTC annual total debt is $5.95 million

    Total debt 1-year change

    -9.93%
    NXTC annual total debt is down -9.93% year-on-year

    Long term debt

    $5.15M
    NXTC annual long term debt is $5.15 million

    Short term debt

    $796.00K
    NXTC annual short term debt is $796.00 thousand

    Equity & Capital

    Shareholders equity

    $65.47M
    NXTC annual stockholders equity is $65.47 million

    Book value

    $65.47M
    NXTC annual book value is $65.47 million

    Retained earnings

    -$380.14M
    NXTC annual retained earnings is -$380.14 million

    Working capital

    $62.23M
    NXTC annual working capital is $62.23 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$40.80M
    NXTC annual cash flow from operations is -$40.80 million

    Cash from operations 1-year change

    +22.97%
    NXTC annual cash flow from operations is up +22.97% year-on-year

    Cash from investing

    $55.31M
    NXTC annual cash flow from investing activities is $55.31 million

    Cash from investing 1-year change

    +40.83%
    NXTC annual cash flow from investing activities is up +40.83% year-on-year

    Cash from financing

    $144.00K
    NXTC annual cash flow from financing activities is $144.00 thousand

    Cash from financing 1-year change

    -6.49%
    NXTC annual cash flow from financing activities is down -6.49% year-on-year

    CAPEX

    CAPEX

    $474.00K
    NXTC annual capital expenditures is $474.00 thousand

    CAPEX 1-year change

    -42.2%
    NXTC annual capital expenditures is down -42.2% year-on-year

    Free Cash Flow

    Free cash flow

    -$41.28M
    NXTC annual free cash flow is -$41.28 million

    Free cash flow 1-year change

    +23.26%
    NXTC annual free cash flow is up +23.26% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    NXTC annual gross profit margin value is unknown

    Operating margin

    -
    NXTC annual operating profit margin value is unknown

    Net margin

    -
    NXTC annual net profit margin value is unknown

    ROA & ROE

    ROA

    -52.67%
    NXTC annual return on assets is -52.67%

    ROE

    -61.87%
    NXTC annual return on equity is -61.87%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    NXTC price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    NXTC price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.48
    NXTC price to book ratio is 0.48

    PB ratio Sector rank

    24.33%
    NXTC price to book ratio is higher than 24.33% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    NXTC price to sales ratio value is unknown

    PS ratio Sector rank

    -
    NXTC price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -$14.84M
    NXTC enterprise value is -$14.84 million

    Enterprise value Sector rank

    4.65%
    NXTC enterprise value is higher than 4.65% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    0.24
    NXTC EV/EBITDA is 0.24

    EV/EBITDA Sector rank

    68.88%
    NXTC EV/EBITDA is higher than 68.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    7.50
    NXTC annual current ratio is 7.50

    Quick ratio

    7.50
    NXTC annual quick ratio is 7.50

    Leverage

    Debt to equity

    0.09
    NXTC annual debt to equity ratio is 0.09

    Interest coverage ratio

    -
    NXTC annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    NXTC piotroski f-score value is unknown

    Altman Z-Score

    -7.34
    NXTC altman z-score is -7.34

    Analyst ratings

    Recent major analysts updates

    Jul 15, 25 Piper Sandler
    Overweight
    Jul 1, 25 HC Wainwright & Co.
    Buy
    Mar 17, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Aug 2, 24 Needham
    Buy
    Jun 3, 24 HC Wainwright & Co.
    Buy
    May 31, 24 HC Wainwright & Co.
    Buy
    May 3, 24 Needham
    Buy
    May 3, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with NXTC included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for NextCure, Inc.?
    • Does NextCure, Inc. pay dividends?
    • What sector is NextCure, Inc. in?
    • What industry is NextCure, Inc. in?
    • What country is NextCure, Inc. based in?
    • When did NextCure, Inc. go public?
    • Is NextCure, Inc. in the S&P 500?
    • Is NextCure, Inc. in the NASDAQ 100?
    • Is NextCure, Inc. in the Dow Jones?
    • When was NextCure, Inc.'s last earnings report?
    • When does NextCure, Inc. report earnings?

    What is the ticker symbol for NextCure, Inc.?

    The ticker symbol for NextCure, Inc. is NASDAQ:NXTC

    Does NextCure, Inc. pay dividends?

    No, NextCure, Inc. does not pay dividends

    What sector is NextCure, Inc. in?

    NextCure, Inc. is in the Healthcare sector

    What industry is NextCure, Inc. in?

    NextCure, Inc. is in the Biotechnology industry

    What country is NextCure, Inc. based in?

    NextCure, Inc. is headquartered in United States

    When did NextCure, Inc. go public?

    NextCure, Inc.'s initial public offering (IPO) was on May 9, 2019

    Is NextCure, Inc. in the S&P 500?

    No, NextCure, Inc. is not included in the S&P 500 index

    Is NextCure, Inc. in the NASDAQ 100?

    No, NextCure, Inc. is not included in the NASDAQ 100 index

    Is NextCure, Inc. in the Dow Jones?

    No, NextCure, Inc. is not included in the Dow Jones index

    When was NextCure, Inc.'s last earnings report?

    NextCure, Inc.'s most recent earnings report was on August 7, 2025

    When does NextCure, Inc. report earnings?

    The date for NextCure, Inc.'s next earnings report has not been announced yet
    On this page